Browsing: Marius Pharmaceuticals

The agency states that the changes are based on a review of more recent clinical evidence.

Shah, whose company developed the oral testosterone drug Kyzatrex, urged regulators to broaden treatment access and align policy with modern science and preventive healthcare goals.

From nutrition and sleep to peptides and regenerative medicine, here’s how to build a long life you can actually sustain.

Marius Pharmaceuticals, which helped secure FDA removal of Black Box Warning, says regulatory shift marks a milestone for patient access and treatment options.

From Novavax to global equities, Raleigh, NC -based Shah Capital’s founder shares his investment philosophy and strategy

The campaign seeks to illuminate the impact of testosterone deficiency on men’s health.

Kyzatrex could be a potential blockbuster to treat testosterone deficiency, a severely undertreated disease.